| Name | Tariff | BNF Sub Paragraph | |
| Insulin isophane human
10 units/ml suspension for injection 10ml vials Pack of 1 | £7.48 |  Intermediate And Long-Acting Insulins |    |
| Humulin I Vial
10 ml Vial (100units / ml) Pack of 1 | £15.68 | Intermediate And Long-Acting Insulins | |
| Humulin M3 Vial
10 ml Vial (100units / ml) Pack of 1 | £15.68 | Intermediate And Long-Acting Insulins | |
| Humulin I Cartridge
3 ml Cartridge Pack of 5 | £19.08 | Intermediate And Long-Acting Insulins | |
| Humulin I Preloaded Pen
3 ml Disposable Pen (kwikpen) Pack of 5 | £21.70 | Intermediate And Long-Acting Insulins | |
| Humulin M3 Preloaded Pen
3 ml Disposable Pen (kwikpen) Pack of 5 | £21.70 | Intermediate And Long-Acting Insulins | |
| Insulin Isophane Human (Insulatard Penfill)
100 units/ml suspension for injection 3ml cartridge Pack of 5 | £22.90 | Intermediate And Long-Acting Insulins | |
Due to be discontinued, it is anticipated stock will run until June 2025 |
| NovoMix 30 Cartridge (Penfill)
3 ml penfill cartridge Pack of 5 | £28.79 | Intermediate And Long-Acting Insulins | |
| Humalog Mix25 Cartridge
3 ml Cartridge Pack of 5 | £29.46 | Intermediate And Long-Acting Insulins | |
| NovoMix 30 Prefilled Pen (FlexPen )
3 ml pre-filled pen Pack of 5 | £29.89 | Intermediate And Long-Acting Insulins | |
| Humalog Mix25 Prefilled Pen
3 ml Disposable Pen Pack of 5 | £30.98 | Intermediate And Long-Acting Insulins | |
| Insulin glargine (Abasaglar)
100 units/ml solution for injection 3ml cartridges Pack of 5 | £35.28 | Intermediate And Long-Acting Insulins | |
| Insulin glargine (Abasaglar KwikPen)
100 units/ml solution for injection 3ml pre-filled pen Pack of 5 | £35.28 | Intermediate And Long-Acting Insulins | |
| Insulin Detemir (Levemir Flexpen)
3 ml preloaded pen Pack of 5 | £42.00 | Intermediate And Long-Acting Insulins | |
Advanced warning that Levemir products are due to be discontinued in 2026, advice is not to initiate any new patients on Levemir products. |
| Insulin Detemir (Levemir Penfill)
3 ml cartridge Pack of 5 | £42.00 | Intermediate And Long-Acting Insulins | |
Advanced warning that Levemir products are due to be discontinued in 2026, advice is not to initiate any new patients on Levemir products. |
| Insulin Glargine (Lantus)
10 ml vial (100units / ml) Pack of 1 | £25.69 |  Intermediate And Long-Acting Insulins | |
| Insulin Glargine (Lantus)
3 ml cartridge (for OptiPen / Autopen) Pack of 5 | £34.75 | Intermediate And Long-Acting Insulins | |
| Insulin Glargine (Lantus)
3 ml SoloStar pen Pack of 5 | £34.75 | Intermediate And Long-Acting Insulins | |
| Insulin Glargine (Lantus)
3 ml OptiSet pen Pack of 5 | £41.50 | Intermediate And Long-Acting Insulins | |
| Insulin Degludec (Tresiba)
100 u / ml (3ml cartridge) (Penfill) Pack of 5 | £46.60 | ![PCT FORMULARY STATUS: Specialist Initiated Drugs [Notes:] Approved for use in the treatment of type 1 diabetes mellitus in adults, adolescents and children from the age of one year, who are under the care of the paediatric diabetes service](/images/bullets/orangebutton.gif) Intermediate And Long-Acting Insulins | |
Approved for use in the treatment of type 1 diabetes mellitus in adults, adolescents and children from the age of one year, who are under the care of the paediatric diabetes service |
| Insulin Degludec (Tresiba Flextouch)
100 u/ml (3ml prefilled pen) Pack of 5 | £46.60 | Intermediate And Long-Acting Insulins | |
Insulin degludec (Tresiba) - approved for use in the treatment of type 1 diabetes mellitus in adults, adolescents and children from the age of one year, who are under the care of the paediatric diabetes service. |
| Insulin Degludec (Tresiba Flextouch)
200 u/ml (3ml prefilled pen) Pack of 3 | £55.92 | Intermediate And Long-Acting Insulins | |
Insulin degludec (Tresiba) - approved for use in the treatment of type 1 diabetes mellitus in adults, adolescents and children from the age of one year, who are under the care of the paediatric diabetes service. |
| Insulin degludec / Liraglutide (Xultophy)
100 units/ml/Liraglutide 3.6mg/ml solution for injection 3ml pre-filled pen Pack of 5 | £159.22 | Intermediate And Long-Acting Insulins | |
Xultophy, a combination of liraglutide/insulin degludec, is accepted onto the formulary for patients intolerant of at least two GLP-1 agonists and who may also be on insulin. Prescribing of Xultophy will be undertaken by the Diabetes Team for the first month and guidance on how Xultophy will be titrated up (and any existing insulin titrated down) will be provided by the Diabetes Team. Patients on Xultophy will be supervised by the Team for about 12 months. |